发布求助
文献互助 智能选刊 最新文献

Actualites Pharmaceutiques最新文献

筛选
英文 中文
Les nouveaux produits de synthèse au cœur du trafic de stupéfiants mondial 处于全球毒品贸易核心的新型合成产品
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.007
Linda Amrouche (Titulaire d’un master 2 en pharmacologie préclinique et clinique)
{"title":"Les nouveaux produits de synthèse au cœur du trafic de stupéfiants mondial","authors":"Linda Amrouche (Titulaire d’un master 2 en pharmacologie préclinique et clinique)","doi":"10.1016/j.actpha.2025.03.007","DOIUrl":"10.1016/j.actpha.2025.03.007","url":null,"abstract":"<div><div>Les nouveaux produits de synthèse sont des substances dérivées de drogues déjà connues, comme la cocaïne et les amphétamines, qui ont la particularité de ne pas avoir de statut juridique défini. Ces nouvelles molécules sont inconnues des scientifiques et des autorités, ce qui les rend éminemment nocives. De nombreux cas d’intoxications et de décès ont été répertoriés à travers le monde. Face à ce fléau, les États disposent de moyens de lutte nationaux et s’organisent également à l’international en formant des coalitions qui ont pour but de freiner le trafic de stupéfiants.</div></div><div><div>New synthetic products are substances derived from drugs already known, such as cocaine and amphetamines, which have the peculiarity of having no defined legal status. These new molecules are unknown to scientists and the authorities, which makes them eminently harmful. Numerous cases of intoxication and death have been reported worldwide. Faced with this scourge, states have their own national means of combating it, and are also organizing themselves internationally by forming coalitions to curb drug trafficking.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 26-28"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manager les équipes officinales avec réalisme et bienveillance 以现实主义和关怀管理办公室团队
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.001
Vincent Chagué (Maître de conférences des universités, docteur en sciences de gestion, consultant en management)
{"title":"Manager les équipes officinales avec réalisme et bienveillance","authors":"Vincent Chagué (Maître de conférences des universités, docteur en sciences de gestion, consultant en management)","doi":"10.1016/j.actpha.2025.03.001","DOIUrl":"10.1016/j.actpha.2025.03.001","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Page 1"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On vous demande, sachez répondre 有人问你，知道如何回答
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.003
Édouard Fougere (Docteur en pharmacie, pharmacien enseignant)
{"title":"On vous demande, sachez répondre","authors":"Édouard Fougere (Docteur en pharmacie, pharmacien enseignant)","doi":"10.1016/j.actpha.2025.03.003","DOIUrl":"10.1016/j.actpha.2025.03.003","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 13-14"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Un cas d’angiœdème bradykinique 1例性血管水肿
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.004
Emmanuel Gachiniard (Pharmacien, praticien hospitalier contractuel)
{"title":"Un cas d’angiœdème bradykinique","authors":"Emmanuel Gachiniard (Pharmacien, praticien hospitalier contractuel)","doi":"10.1016/j.actpha.2025.03.004","DOIUrl":"10.1016/j.actpha.2025.03.004","url":null,"abstract":"<div><div>L’angiœdème bradykinique (AOB) représente un effet indésirable rare mais potentiellement grave, souvent associé aux inhibiteurs de l’enzyme de conversion comme le lisinopril, mais aussi aux gliptines utilisées dans le diabète de type 2, telles que la vildagliptine. Dans ce contexte, le rôle du pharmacien est essentiel pour identifier les médicaments à risque d’AOB au comptoir.</div></div><div><div>Bradykin angioedema (BAE) is a rare but potentially serious side effect, often associated with ACE inhibitors such as lisinopril, but also with gliptins used in type 2 diabetes, such as vildagliptin. In this context, the role of the pharmacist is essential in identifying drugs at risk of AOB at the counter.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 15-18"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De la plante au laboratoire 从植物到实验室
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.006
Anne-Solène Naudon (Docteure en pharmacie)
{"title":"De la plante au laboratoire","authors":"Anne-Solène Naudon (Docteure en pharmacie)","doi":"10.1016/j.actpha.2025.03.006","DOIUrl":"10.1016/j.actpha.2025.03.006","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Page 25"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les cannabinoïdes de synthèse, une consommation en hausse 合成大麻素的使用增加
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.008
André Nguyen (Docteur en pharmacie, pharmacien, coordinateur général)
{"title":"Les cannabinoïdes de synthèse, une consommation en hausse","authors":"André Nguyen (Docteur en pharmacie, pharmacien, coordinateur général)","doi":"10.1016/j.actpha.2025.03.008","DOIUrl":"10.1016/j.actpha.2025.03.008","url":null,"abstract":"<div><div>Les cannabinoïdes de synthèse représentaient, en 2022, plus de la moitié des nouveaux produits de synthèse, loin devant les dérivés de la cathinone et des opioïdes. Ils constituent aujourd’hui un vrai enjeu de santé publique en raison de leur puissance et de leur diversité chimique. La régulation de leur usage est complexe, nécessitant une vigilance accrue des autorités et des professionnels de santé.</div></div><div><div>By 2022, synthetic cannabinoids would account for more than half of all new synthetic products, well ahead of cathinone and opioid derivatives. Their potency and chemical diversity make them a real public health issue. Regulating their use is complex, requiring increased vigilance on the part of authorities and healthcare professionals.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 29-32"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
profession 职业
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.04.015
{"title":"profession","authors":"","doi":"10.1016/j.actpha.2025.04.015","DOIUrl":"10.1016/j.actpha.2025.04.015","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 4-5"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le deucravacitinib (Sotyktu®), un nouvel antipsoriasique deucravacitinib （Sotyktu®），一种新的抗牛皮癣药物
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.002
Jacques Buxeraud (Professeur des universités) , Sébastien Faure (Professeur des universités)
{"title":"Le deucravacitinib (Sotyktu®), un nouvel antipsoriasique","authors":"Jacques Buxeraud (Professeur des universités) ,&nbsp;Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2025.03.002","DOIUrl":"10.1016/j.actpha.2025.03.002","url":null,"abstract":"<div><div>Le deucravacitinib est un nouveau médicament qui appartient à la classe des inhibiteurs des Janus kinases. Il est utilisé dans le traitement systémique du psoriasis en plaques modéré à sévère de l’adulte.</div></div><div><div>Deucravacitinib is a new member of the Janus kinase inhibitor class. It is used in the systemic treatment of moderate to severe plaque psoriasis in adults.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 10-12"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Évaluez-vous ! 你!
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-25 DOI: 10.1016/j.actpha.2025.03.016
Élisa Derrien (Rédactrice en chef)
{"title":"Évaluez-vous !","authors":"Élisa Derrien (Rédactrice en chef)","doi":"10.1016/j.actpha.2025.03.016","DOIUrl":"10.1016/j.actpha.2025.03.016","url":null,"abstract":"<div><div>Ce questionnaire à choix multiples (QCM) vous permet de vérifier les connaissances acquises à la lecture du numéro d’<em>Actualités pharmaceutiques</em>.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 646","pages":"Pages 62-64"},"PeriodicalIF":0.1,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Évaluez-vous ! 你!
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-04-01 DOI: 10.1016/j.actpha.2025.03.022
Isabelle Pommier (Docteure en pharmacie) , Jacques buxeraud (Professeur des universités)
{"title":"Évaluez-vous !","authors":"Isabelle Pommier (Docteure en pharmacie) ,&nbsp;Jacques buxeraud (Professeur des universités)","doi":"10.1016/j.actpha.2025.03.022","DOIUrl":"10.1016/j.actpha.2025.03.022","url":null,"abstract":"<div><div>Ce QCM vous permet de vérifier les connaissances acquises à la lecture de ce numéro du <em>Carnet du préparateur en pharmacie</em>.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 647","pages":"Page 21"},"PeriodicalIF":0.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144089042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信